- Copper transport disease
- Kinky hair disease
- Menkea syndrome
- Menkes syndrome
- Steely hair disease
News & Events
On this page
ORDR Co-Sponsored Conferences
Human Disorders of Copper Metabolism: Recent Advances and Main Challenges, Monday, April 08, 2013 - Tuesday, April 09, 2013
Location: Johns Hopkins University, Baltimore, MD
Description: The main goal of the proposed workshop is to stmulate interactions and collaborations between clinical and basic science researchers by highlighting important issues associated with disturbances of copper metabolism in humans and most recent methodologic advances.
The Tenth International Catecholamine Symposium (XICS), Sunday, September 09, 2012 - Thursday, September 13, 2012
Location: Ailomar Conference Grounds, Pacific Grove, CA
Description: The Tenth International Catecholamine Symposium (XICS) will emphasize integration of basic science with clinical pathophysiology, by a program centering on disease-oriented research about catecholamine systems. The goals of the XICS are to: disseminate the latest important basic scientific, disease-oriented, and patient-oriented medical advances about catecholamines; foster interactions among basic scientists, disease-oriented researchers, and clinical investigators, via common interests in catecholamine systems; emphasize integrative approaches for understanding the roles of catecholamines in cellular, organ, systemic, and organismic integrity; comprehensively update research on catecholamines in rare and common disorders of development in pediatrics, regulation in adults, and degeneration in the elderly; and foster synthesis of molecular genetics with integrative physiology and pathophysiology, based on evolving understanding of catecholamine systems.
Research Challenges in CNS Manifestations of Inborn Errors of Metabolism Workshop, Monday, December 07, 2009 - Wednesday, December 09, 2009
Location: Bethesda North Marriott, Bethesda, Maryland
Description: Jointly sponsored by the National Institute of Health's Office Rare Diseases Research, the National Institute of Neurological Disorders and Stroke, and the Food and Drug Administration's Center for Drug Evaluation and Research, Division of Gastroenterology Products, the goal of this workshop is to bring together those involved in research and investigational treatments for central nervous system aspects of inborn errors of metabolism, and to discuss ways to translate these therapies to clinical trials and beyond.